Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSEN1 | P49768 | 6/20 | 0.38 |
| ▸ | PSEN2 | P49810 | 6/20 | 0.38 |
| ▸ | APH1B | Q8WW43 | 6/20 | 0.38 |
| ▸ | NCSTN | Q92542 | 6/20 | 0.38 |
| ▸ | APH1A | Q96BI3 | 6/20 | 0.38 |
| ▸ | PSENEN | Q9NZ42 | 6/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 10/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.35 |
| ▸ | PLD2 | O14939 | 2/20 | 0.35 |
| ▸ | PLD1 | Q13393 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11304464 | 0.88 | HDAC8 (0.37) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11301754 | 0.87 | PSEN1 (0.42) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11303268 | 0.86 | ABL1 (0.37) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11303351 | 0.86 | HDAC6 (0.40) | HDAC8HDAC6HDAC1 | |
| SCHEMBL11303328 | 0.84 | HDAC8 (0.37) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11300698 | 0.83 | PSEN1 (0.36) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11298752 | 0.83 | HDAC8 (0.42) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11305647 | 0.82 | HDAC6 (0.41) | HDAC8HDAC6HDAC1 | |
| SCHEMBL11299163 | 0.82 | HDAC6 (0.40) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL11296595 | 0.81 | HDAC6 (0.42) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2665706-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F.HOFFMANN-LA ROCHE AG (CH) | 2013-11-27 | — | — | EP | claimed |
| WO-2012098132-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2012-07-26 | — | — | WO | claimed |
| EP-2665706-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F.HOFFMANN-LA ROCHE AG (CH) | 2013-11-27 | — | — | EP | disclosed |
| WO-2012098132-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2012-07-26 | — | — | WO | disclosed |